Similar articles

• Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.

  Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, Tsuboi M, Tada H, Kuwano H, Mitsudomi T. Kosaka T, et al. Clin Cancer Res. 2006 Oct 1;12(19):5764-9. doi: 10.1158/1078-0432.CCR-06-0714. Clin Cancer Res. 2006. PMID: 17020982
• Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

  Inukai M, Toyooka S, Ito S, Asano H, Ichihara S, Soh J, Suehisa H, Ouchida M, Aoe K, Aoe M, Kiura K, Shimizu N, Date H. Inukai M, et al. Cancer Res. 2006 Aug 15;66(16):7854-8. doi: 10.1158/0008-5472.CAN-06-1951. Cancer Res. 2006. PMID: 16912157
• Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.

  Willmore-Payne C, Holden JA, Layfield LJ. Willmore-Payne C, et al. Hum Pathol. 2006 Jun;37(6):755-63. doi: 10.1016/j.humpath.2006.02.004. Hum Pathol. 2006. PMID: 16733218
• Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity.

  Suda K, Mitsudomi T. Suda K, et al. Arch Toxicol. 2015 Aug;89(8):1227-40. doi: 10.1007/s00204-015-1524-7. Epub 2015 May 17. Arch Toxicol. 2015. PMID: 25983263 Review.
• Update on epidermal growth factor receptor mutations in non-small cell lung cancer.

  Riely GJ, Politi KA, Miller VA, Pao W. Riely GJ, et al. Clin Cancer Res. 2006 Dec 15;12(24):7232-41. doi: 10.1158/1078-0432.CCR-06-0658. Clin Cancer Res. 2006. PMID: 17189394 Review.